Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808

Authors: Carthon, Bradley C., Kim, Se Eun, McDermott, David F., Dutcher, Janice P., Puligandla, Maneka, Manola, Judith, Pins, Michael, Carducci, Michael A., Plimack, Elizabeth R., Appleman, Leonard J., MacVicar, Gary R., Kohli, Manish, Kuzel, Timothy M., DiPaola, Robert S., Haas, Naomi B.

Source: In Clinical Genitourinary Cancer October 2023 21(5):546-554

Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: post hoc analysis from Eastern Cooperative Oncology Group‐American College of Radiology Imaging Network (ECOG‐ACRIN) E2805

Authors: Karam, Jose A., Puligandla, Maneka, Flaherty, Keith T., Uzzo, Robert G., Matin, Surena F., Pins, Michael R., Wood, Christopher G., Kane, Christopher, Jewett, Michael A. S., Kim, Se Eun, Dutcher, Janice P., DiPaola, Robert S., Haas, Naomi B.

Source: BJU international. 129(6):718-722

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100151212362.0x000001&indx=1&recIds=ETOCvdc_100151212362.0x000001

Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma

Authors: Correa, Andres F., Jegede, Opeyemi A., Haas, Naomi B., Flaherty, Keith T., Pins, Michael R., Adeniran, Adebowale, Messing, Edward M., Manola, Judith, Wood, Christopher G., Kane, Christopher J., Jewett, Michael A.S., Dutcher, Janice P., DiPaola, Robert S., Carducci, Michael A., Uzzo, Robert G.

Source: In European Urology July 2021 80(1):20-31

Families with multiple individuals with acute leukemia in their pedigrees.

Authors: Wiernik, Peter H, Blakley, Matthew P, Dutcher, Janice P

Source: Journal of Investigative Medicine (Sage Publications Inc.); Dec2024, Vol. 72 Issue 8, p842-847, 6p

NCI 6896: a phase I trial of vorinostat (SAHA) and isotretinoin (13-cis retinoic acid) in the treatment of patients with advanced renal cell carcinoma

Authors: Molina, Ana M., van der Mijn, Johannes C., Christos, Paul, Wright, John, Thomas, Charlene, Dutcher, Janice P., Nanus, David M., Tagawa, Scott T., Gudas, Lorraine J.

Source: Investigational new drugs. 38(5):1383-1389

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100171295785.0x000001&indx=1&recIds=ETOCvdc_100171295785.0x000001

Pulmonary Langerhans cell histiocytosis, acute myeloid leukemia, and myelofibrosis in a large family and review of the literature

Authors: Blakley, Matthew P., Dutcher, Janice P., Wiernik, Peter H.

Source: In Leukemia Research April 2018 67:39-44

Association between age and sex and mortality after adjuvant therapy for renal cancer

Authors: Mamtani, Ronac, Wang, Xin Victoria, Gyawali, Bishal, DiPaola, Robert S., Epperson, C. Neill, Haas, Naomi B., Dutcher, Janice P.

Source: Cancer. 125(10):1637-1644

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100090540962.0x000001&indx=1&recIds=ETOCvdc_100090540962.0x000001

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition

Authors: Buchbinder, Elizabeth, Dutcher, Janice, Daniels, Gregory, Curti, Brendan, Patel, Sapna, Holtan, Shernan, Miletello, Gerald, Fishman, Mayer, Gonzalez, Rene, Clark, Joseph, Richart, John, Lao, Christopher, Tykodi, Scott, Silk, Ann, McDermott, David

Source: Journal for immunotherapy of cancer. 7(1):1-7

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100186497014.0x000001&indx=1&recIds=ETOCvdc_100186497014.0x000001

A Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients With Metastatic Renal Cell Carcinoma (ECOG-ACRIN [E4805])

Authors: Pili, Roberto, Jegede, Opeyemi, Carducci, Michael A., Manola, Judith, Groteluschen, David L., Appleman, Leonard L., Liu, Glenn, Shanks, James C., Dakhil, Shaker R., Dutcher, Janice, DiPaola, Robert S.

Source: In Clinical Genitourinary Cancer December 2017 15(6):642-651

Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810.

Authors: Appleman, Leonard J., Kim, Se Eun, Harris, Wayne B., Pal, Sumanta K., Pins, Michael R., Kolesar, Jill, Agarwal, Neeraj, Parikh, Rahul A., Vaena, Daniel A., Ryan, Christopher W., Hashmi, Mehmood, Costello, Brian A., Cella, David, Dutcher, Janice P., DiPaola, Robert S., Haas, Naomi B., Wagner, Lynne I., Carducci, Michael A.

Source: Journal of Clinical Oncology; 6/10/2024, Vol. 42 Issue 17, p2061-2070, 17p

Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIMSM

Authors: Clark, Joseph I., Wong, Michael K.K., Kaufman, Howard L., Daniels, Gregory A., Morse, Michael A., McDermott, David F., Agarwala, Sanjiv S., Lewis, Lionel D., Stewart, John H., Vaishampayan, Ulka, Curti, Brendan, Gonzalez, René, Lutzky, Jose, Rudraptna, Venkatesh, Cranmer, Lee D., Jeter, Joanne M., Hauke, Ralph J., Miletello, Gerald, Milhem, Mohammed M., Amin, Asim, Richart, John M., Fishman, Mayer, Hallmeyer, Sigrun, Patel, Sapna P., Van Veldhuizen, Peter, Agarwal, Neeraj, Taback, Bret, Treisman, Jonathan S., Ernstoff, Marc S., Perritt, Jessica C., Hua, Hong, Rao, Tharak B., Dutcher, Janice P., Aung, Sandra

Source: In Clinical Genitourinary Cancer February 2017 15(1):31-41

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial

Authors: Haas, Naomi B, Manola, Judith, Uzzo, Robert G, Flaherty, Keith T, Wood, Christopher G, Kane, Christopher, Jewett, Michael, Dutcher, Janice P, Atkins, Michael B, Pins, Michael, Wilding, George, Cella, David, Wagner, Lynne, Matin, Surena, Kuzel, Timothy M, Sexton, Wade J, Wong, Yu-Ning, Choueiri, Toni K, Pili, Roberto, Puzanov, Igor, Kohli, Manish, Stadler, Walter, Carducci, Michael, Coomes, Robert, DiPaola, Robert S

Source: In The Lancet 14-20 May 2016 387(10032):2008-2016

Families with non-Hodgkin lymphoma and plasma cell dyscrasias in their pedigrees.

Authors: Wiernik, Peter H, Dutcher, Janice P

Source: Journal of Investigative Medicine (Sage Publications Inc.); Jan2024, Vol. 72 Issue 1, p26-31, 6p

Atrasentan in Patients With Advanced Renal Cell Carcinoma: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E6800)

Authors: Carducci, Michael A., Manola, Judith, Nair, Suresh G., Liu, Glenn, Rousey, Steven, Dutcher, Janice P., Wilding, George

Source: In Clinical Genitourinary Cancer December 2015 13(6):531-539

Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry

Authors: Curti, Brendan, Daniels, Gregory, McDermott, David, Clark, Joseph, Kaufman, Howard, Logan, Theodore, Singh, Jatinder, Kaur, Meenu, Luna, Theresa, Gregory, Nancy, Morse, Michael, Wong, Michael, Dutcher, Janice

Source: Journal for immunotherapy of cancer. 5(1):1-9

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100162513948.0x000001&indx=1&recIds=ETOCvdc_100162513948.0x000001

Gender effects in cancer treatment and outcome

Authors: Dutcher, Janice P.

Source: British journal of haematology. 194(2):229-230

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100142027655.0x000001&indx=1&recIds=ETOCvdc_100142027655.0x000001

Transcription Factor E3 and Transcription Factor EB Renal Cell Carcinomas: Clinical Features, Biological Behavior and Prognostic Factors

Authors: Malouf, Gabriel G. ^†, Camparo, Philippe ^†, Molinié, Vincent ^†, Dedet, Guillaume ^†, Oudard, Stéphane ^†, Schleiermacher, Gudrun ^†, Theodore, Christine ^†, Dutcher, Janice ^‡, Billemont, Bertrand ^†, Bompas, Emmanuelle ^†, Guillot, Aline ^†, Boccon-Gibod, Liliane ^†, Couturier, Jérôme ^†, Escudier, Bernard ^§

Source: In The Journal of Urology 2011 185(1):24-29

State-of-the-Art Management of Renal Cell Carcinoma

Authors: Mourad, Waleed Fouad, Dutcher, Janice, Ennis, Ronald D.

Source: American journal of clinical oncology. 37(5):498-505

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100030154823.0x000001&indx=1&recIds=ETOCvdc_100030154823.0x000001

Clinical Trial Experience With Temsirolimus in Patients With Advanced Renal Cell Carcinoma

Authors: Hudes, Gary R., Berkenblit, Anna, Feingold, Jay, Atkins, Michael B., Rini, Brian I., Dutcher, Janice

Source: In Seminars in Oncology 2009 36 Supplement 3:S26-S36

Renal Medullary Carcinoma: The Bronx Experience

Authors: Hakimi, A. Ari, Koi, Phillip T., Milhoua, Paul M., Blitman, Netta M., Li, Maomi, Hugec, Vladimir, Dutcher, Janice P., Ghavamian, Reza

Source: In Urology 2007 70(5):878-882